|
Delayed
Toronto S.E.
15:59:42 2026-09-01 EDT
|
5-day change | 1st Jan Change | ||
| 15.87 CAD | -0.75% |
|
+1.08% | +24.67% |
| 08-21 | Earnings Flash (RX.V) BioSyent Inc. Reports Q2 Revenue C$19.9M | MT |
| 08-20 | Tranche Update on BioSyent Inc. (TSXV:RX)'s Equity Buyback Plan announced on December 15, 2025. | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
- Stock Market
- Stocks
- RX Stock
- Consensus BioSyent Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
